Liquid biopsy: unveiling methylation biomarkers for early cancer diagnosis

16 December 2024

Liquid biopsy represents a groundbreaking advancement in disease diagnostics, offering a less invasive alternative to traditional tissue biopsies, particularly for cancer.

5‑methylcytosine and 5‑hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer

Read our bioRXiv preprint: 5‑methylcytosine and 5‑hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer

25 November 2024

Our study investigates the roles of 5‑methylcytosine (5mC) and 5‑hydroxymethylcytosine (5hmC) as biomarkers for early-stage colorectal cancer (CRC) detection in cell-free DNA (cfDNA).

How liquid biopsy utilises genetic biomarkers for early diagnosis

18 November 2024

The utilisation of genetic biomarkers in liquid biopsy has caused a revolution in cancer diagnostics and personalised medicine.

Products

Discover

duet multiomics solution evoC

duet multiomics solution +modC

Applications and research areas

Explore

Cancer research

Neurodegenerative disease

Ageing

Precision medicine

Liquid biopsy

Resources

Learn

Resource library

Customer documentation portal

About biomodal

Connect

About

Leadership

News

Events

Certified Service Provider

Careers

Contact

Article from Cancer Research UK Website

Keep reading